🇺🇸 FDA
Patent

US 10494619

High isomerohydrolase activity mutants of human RPE65

granted A61KA61K48/00A61P

Quick answer

US patent 10494619 (High isomerohydrolase activity mutants of human RPE65) held by The Board of Regents of the University of Oklahoma expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K48/00, A61P, A61P27/02